Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study
Table 2
Reasons for initiation of antiretroviral therapy (ART) within the RPV/TDF/FTC group (EPA) and the control group; overall p <0.001.